Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2k) male mice

Human Immunology

Volumn 69, Issue 12, 2008, Pages 845-850

  Sinkorova Z ^a   Capkova J ^b   Niederlova J ^c   Stepankova R ^d   Sinkora J ^d  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^c Hospital of Saint Elisabeth   (Czech Republic)

^d INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Ankylosing enthesopathy; Ankylosing spondylitis; Intestinal microflora; Mice; Spondyloarthropathies

Indexed keywords

RIBOSOME DNA;

ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ANKYLOSING ENTHESOPATHY; ARTHRITIS; ARTICLE; BACTERIAL STRAIN; BACTEROIDES; COMMENSAL; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; ENTEROCOCCUS; ENTHESOPATHY; EXPERIMENTAL STUDY; GERMFREE ANIMAL; INTESTINE FLORA; LACTOBACILLUS; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES CULTIVATION; STAPHYLOCOCCUS; VEILLONELLA;

ANIMALS; DNA, BACTERIAL; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; IMMUNITY, MUCOSAL; INTESTINES; MALE; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; SPONDYLITIS, ANKYLOSING;

EID: 57649089008     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.08.296     Document Type: Article

References (48)

1. Granforcs K., Marker-Hermann E., de Keyser F., et al. The cutting edge of spondylarthropathy research in the millennium. Arthritis Rheum 46 (2002) 606-613
2. D'Agostino M.A., Said-Nahal R., Hacquard-Bouder C., et al. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 48 (2003) 523-533
3. Khan M.A. An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum Dis Clin North Am 18 (1992) 1-10
4. Khan M.A., and Kellner H. Immunogenetics of spondyloarthropathies. Rheum Dis Clin North Am 18 (1992) 837-864
5. Hammer R.E., Maika S.D., Richardson J.A., et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63 (1990) 1099-1112
6. Ivanyi P., Eulderink F., van Alphen L., et al. Joint disease in B27 transgenic mice. In: Lipsky P.E., and Taurog J.D. (Eds). Proceedings of the Second International Simmons Center, Conference on HLA-B27-Related Disorders (1991), Elsevier, Amsterdam
7. Taurog J.D., Maika S.D., Simmons W.A., et al. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150 (1993) 4168-4178
8. 2-microglobulin: a model of human spondylarthopathies. J Exp Med 182 (1995) 1153-1158
9. Taurog J.D., Maika S.D., Satumtira N., et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 169 (1999) 209-223
10. Breban M., Hacquard-Bouder C., and Falgarone G. Animal models of HLA-B27-associated diseases. Curr Mol Med 4 (2004) 21-40
11. Čapková J., and Ivanyi P. H-2 influence on ankylosing enthesopathy of the ankle (ANKENT). Folia Biol (Prague) 38 (1992) 258-262
12. Weinreich S., Eulderink F., Čapková J., et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol 42 (1995) 103-115
13. Eulderink F., Ivanyi P., and Weinreich S. Histopathology of murine ankylosing enthesopathy. Pathol Res Pract 194 (1998) 797-803
14. k) male mice. Ann Rheum Dis 66 (2006) 130-132
15. Gerard H.C., Branigan P.J., Schumacher Jr. H.R., et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 25 (1998) 734-742
16. Ekman P., Kirveskari J., and Granfors K. Modification of disease outcome in Salmonella-infected patients by HLA-B27. Arthritis Rheum 43 (2000) 1527-1534
17. Řeháková Z., Čapková J., Štěpánková R., et al. Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum Immunol 61 (2000) 555-558
18. Weinreich S., Capkova J., Hoebe-Hewryk B., et al. Grouped caging predisposes male mice to ankylosing enthesopathy. Ann Rheum Dis 55 (1996) 645-647
19. Taurog J.D., Richardson J.A., Croft J.T., et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180 (1994) 2359-2364
20. 2-microglobulin transgenic rats. J Clin Invest 98 (1996) 945-953
21. Rath H.C., Wilson K.H., and Sartor R.B. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 67 (1999) 2969-2974
22. Štěpánková R. Rearing germfree rats and rabbits. Folia Microbiol 24 (1979) 11-15
23. Maidak B.L., Cole J.R., Lilburn T.G., et al. The RDP-II (Ribosomal Database Project). Nucleic Acids Res 29 (2001) 173-174
24. Salzman N.H., de Jong H., Paterson Z., et al. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 148 (2002) 3651-3660
25. http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi.
26. Hudcovic T., Štěpánková R., Cebra H., et al. The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol 46 6 (2001) 565-572
27. Čapková J., Štěpánková R., Hudcovic T., et al. Experimental colitis does not increase the prevalence of ANKENT, a spontaneous joint disease in mice. Folia Microbiol 49 6 (2004) 745-750
28. Leirisalo-Repo M., Hannu T., and Mattila L. Microbial factors in spondyloarthropathies: insight from population studies. Curr Opin Rheumatol 15 (2003) 408-412
29. Mielants H., Veys E.M., Cuvelier C., et al. The evolution of spondylarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 29 (1995) 2279-2284
30. Protzer U., Duchmann R., Hohler T., et al. Enteropathic spondylarthritis in chronic inflammatory bowel disease: prevalence, manifestation pattern and HLA association. Med Klin 91 (1996) 330-335
31. de Vlam K., Mielants H., Cuvelier C., et al. Spondyloarthropathy is understimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27 (2000) 2860-2865
32. Palm O., Moum B., Ongre A., et al. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study. J Rheumatol 29 (2002) 511-515
33. Onderdonk A.B., Franklin M.L., and Cisneros R.L. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun 32 (1981) 225-231
34. Krook A., Lindstrom B., Kjellander J., et al. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals. J Clin Pathol 34 (1981) 645-650
35. Rosenfeldt V., Michaelsen K.F., Jakobsen M., et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhoea. Pediatr Infect Dis 21 (2000) 411-416
36. Forchielli M.L., and Walker W.A. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 93 Suppl 1 (2005) 41-48
37. Fisher R.G., and Denison M.R. Veillonella parvula bacteremia without an underlying source. J Clin Microbiol 34 (1996) 3235-3236
38. Bassetti S., Wasmer S., Hasler P., et al. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor alpha treatment. J. Rheumatol 32 (2005) 2125-2129
39. Chiba M., Hoshina S., Kono M., et al. Staphylococcus aureus in inflammatory bowel disease. Scand J Gastroenterol 36 (2001) 615-620
40. Sartor R.B., Rath H.C., Lichtman S.N., et al. Animals model of intestinal and joint inflammation. Baillieres Clin Rheumatol 10 (1996) 55-76
41. Onderdonk A.B., Richardson J.A., Hammer R.E., et al. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 66 (1998) 6022-6023
42. Dieleman L.A., Goerres M.S., Arends A., et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52 (2003) 370-376
43. Hoentjen F., Welling G.W., Harmsen H.J., et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis 11 (2005) 977-985
44. Appel H., Kuhne M., Spiekermann S., et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 54 (2006) 2845-2851
45. Cunnane G., Bresnihan B., and FitzGerald O. Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 41 (1998) 180-182
46. Kohler S., Thiel A., Rudwaleit M., et al. CD27+ memory and CD27- effector CD8+ T cells are responsible for a decreased production of proinflammatory cytokines in HLA B27-positive subjects. Clin Exp Rheumatol 23 (2005) 840-846
47. Tlaskalova-Hogenova H., Štěpánková R., Hudcovic T., et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93 (2004) 97-108
48. Fasano A., and Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 416-422